CS logo
small CS logo
National Hospital Organization Disaster Medical Center

Tachikawa, Tokyo, Japan
立川市の医療センター

About National Hospital Organization Disaster Medical Center


独立行政法人国立病院機構災害医療センターは、東京都立川市にある医療機関。独立行政法人国立病院機構が運営する病院である。旧国立立川病院及び旧国立王子病院。
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Takeda
2
Amgen
1
Bayer
1
Celgene
1
Janssen Pharmaceutical K.K.
1
Sumitomo Pharma Co., Ltd.
1
Total Rows: 7

Clinical Trials at National Hospital Organization Disaster Medical Center


During the past decade, National Hospital Organization Disaster Medical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33001111110000111100002211221111Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients
2012-06-20
2018-02-05
Completed
929
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
2013-01-07
2022-05-13
Completed
559
A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant
2014-07-01
2025-06-25
Active, not recruiting
656
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
2014-09-30
2018-04-19
Completed
394
A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)
2015-04-09
2022-08-26
Completed
706
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC
2015-04-01
2017-12-01
Completed
719
Study of DSP-7888 in Patients With Myelodysplastic Syndrome
2015-05-01
2020-03-01
Completed
48
Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2017-05-15
2021-03-04
Completed
64

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "National Hospital Organization Disaster Medical Center" #1 sponsor was "Pfizer" with 4 trials, followed by "Takeda" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 4Pfizer: 4Takeda: 2Takeda: 2Amgen: 1Amgen: 1Bayer: 1Bayer: 1Celgene: 1Celgene: 1Janssen Pharmaceutical K.K.: 1Janssen Pharmaceutical K.K.: 1Sumitomo Pharma Co., Ltd.: 1Sumitomo Pharma Co., Ltd.: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at National Hospital Organization Disaster Medical Center


According to Clinical.Site data, the most researched conditions in "National Hospital Organization Disaster Medical Center" are "Multiple Myeloma" (4 trials), "Atrial Fibrillation" (1 trials), "Autologous Stem Cell Transplant" (1 trials), "Follicular Lymphoma" (1 trials) and "Leukemia, Chronic Myelogenous" (1 trials). Many other conditions were trialed in "National Hospital Organization Disaster Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at National Hospital Organization Disaster Medical Center


Most popular intervention types in "National Hospital Organization Disaster Medical Center" are "Drug" (10 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Bortezomib" (2 trials), "Dexamethasone" (2 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at National Hospital Organization Disaster Medical Center


The vast majority of trials in "National Hospital Organization Disaster Medical Center" are 11 trials for "All" genders.

Clinical Trials Status at National Hospital Organization Disaster Medical Center


Currently, there are NaN active trials in "National Hospital Organization Disaster Medical Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in National Hospital Organization Disaster Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Disaster Medical Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 2: 3Phase 2: 3Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1